Display options
Share it on

Front Immunol. 2012 Jul 23;3:213. doi: 10.3389/fimmu.2012.00213. eCollection 2012.

Antimicrobial activities of chemokines: not just a side-effect?.

Frontiers in immunology

Marlene Wolf, Bernhard Moser

Affiliations

  1. Theodor Kocher Institute, University of Bern Bern, Switzerland.

PMID: 22837760 PMCID: PMC3401835 DOI: 10.3389/fimmu.2012.00213

Abstract

The large family of chemoattractant cytokines (chemokines) embraces multiple, in part unrelated functions that go well beyond chemotaxis. Undoubtedly, the control of immune cell migration (chemotaxis) is the single, unifying response mediated by all chemokines, which involves the sequential engagement of chemokine receptors on migrating target cells. However, numerous additional cellular responses are mediated by some (but not all) chemokines, including angiogenesis, tumor cell growth, T-cell co-stimulation, and control of HIV-1 infection. The recently described antimicrobial activity of several chemokines is of particular interest because antimicrobial peptides are thought to provide an essential first-line defense against invading microbes at the extremely large body surfaces of the skin, lungs, and gastrointestinal-urinary tract. Here we summarize the current knowledge about chemokines with antimicrobial activity and discuss their potential contribution to the control of bacterial infections that may take place at the earliest stage of antimicrobial immunity. In the case of homeostatic chemokines with antimicrobial function, such as CXCL14, we propose an immune surveillance function in healthy epithelial tissues characterized by low-level exposure to environmental microbes. Inflammatory chemokines, i.e., chemokines that are produced in tissue cells in response to microbial antigens (such as pathogen-associated molecular patterns) may be more important in orchestrating the cellular arm in antimicrobial immunity.

Keywords: antimicrobial immunity; antimicrobial peptides; chemokines; immune surveillance

References

  1. J Exp Med. 2000 Oct 2;192(7):1069-74 - PubMed
  2. Science. 1963 Nov 22;142(3595):1085-7 - PubMed
  3. Trends Immunol. 2009 Mar;30(3):131-41 - PubMed
  4. J Leukoc Biol. 2000 Jul;68(1):9-14 - PubMed
  5. J Invest Dermatol. 2003 Mar;120(3):379-89 - PubMed
  6. J Biol Chem. 1996 Feb 9;271(6):2935-40 - PubMed
  7. Cell Mol Life Sci. 2003 Apr;60(4):711-20 - PubMed
  8. J Biol Chem. 2000 Jul 7;275(27):20374-81 - PubMed
  9. J Immunol. 2006 Jul 15;177(2):782-6 - PubMed
  10. Exp Dermatol. 2008 Aug;17(8):633-9 - PubMed
  11. J Invest Dermatol. 2010 Dec;130(12):2836-8 - PubMed
  12. J Allergy Clin Immunol. 2009 Sep;124(3 Suppl 2):R13-8 - PubMed
  13. Antimicrob Agents Chemother. 2008 Mar;52(3):883-94 - PubMed
  14. Trends Immunol. 2004 Feb;25(2):75-84 - PubMed
  15. J Invest Dermatol. 2007 Mar;127(3):594-604 - PubMed
  16. Biotechnol Lett. 2005 Sep;27(18):1337-47 - PubMed
  17. J Immunol. 2003 Feb 1;170(3):1452-61 - PubMed
  18. Neurosci Lett. 2011 Jan 10;487(3):335-40 - PubMed
  19. Immunology. 2002 May;106(1):20-6 - PubMed
  20. PLoS One. 2009 Jul 28;4(7):e6395 - PubMed
  21. Eur J Immunol. 2007 Sep;37(9):2474-86 - PubMed
  22. J Biol Chem. 2011 Jan 28;286(4):2469-76 - PubMed
  23. Nat Med. 2006 Jun;12(6):636-41 - PubMed
  24. Eur J Immunol. 2010 Jan;40(1):186-96 - PubMed
  25. J Allergy Clin Immunol. 2003 Dec;112(6):1195-202 - PubMed
  26. Mucosal Immunol. 2010 Jan;3(1):40-8 - PubMed
  27. J Invest Dermatol. 2009 Sep;129(9):2091-3 - PubMed
  28. J Biol Chem. 2002 Oct 4;277(40):37647-54 - PubMed
  29. J Allergy Clin Immunol. 2007 Feb;119(2):457-63 - PubMed
  30. Biochem Biophys Res Commun. 2007 Apr 6;355(2):352-8 - PubMed
  31. FEBS J. 2011 Oct;278(20):3942-51 - PubMed
  32. J Immunol. 2004 Mar 1;172(5):3070-7 - PubMed
  33. Biochem Biophys Res Commun. 2006 Sep 22;348(2):406-12 - PubMed
  34. Nature. 2011 Jan 20;469(7330):419-23 - PubMed
  35. Endocrinology. 2009 Dec;150(12):5596-605 - PubMed
  36. J Biol Chem. 1997 Jun 13;272(24):15258-63 - PubMed
  37. PLoS Pathog. 2010 Nov 18;6(11):e1001199 - PubMed
  38. Pediatr Res. 2003 Apr;53(4):566-72 - PubMed
  39. J Immunol. 2011 Oct 15;187(8):4300-9 - PubMed
  40. J Leukoc Biol. 2004 Jan;75(1):39-48 - PubMed
  41. J Exp Med. 2001 Sep 17;194(6):855-61 - PubMed
  42. Cancer Lett. 2008 Feb 8;259(2):209-17 - PubMed
  43. Science. 1999 Oct 15;286(5439):525-8 - PubMed
  44. J Immunol. 2001 Jul 15;167(2):623-7 - PubMed
  45. Antimicrob Agents Chemother. 2005 Sep;49(9):3889-95 - PubMed
  46. Cancer Res. 2004 Nov 15;64(22):8262-70 - PubMed
  47. Biochim Biophys Acta. 2010 Jun;1798(6):1062-72 - PubMed
  48. J Biol Chem. 2002 Nov 29;277(48):46779-84 - PubMed
  49. Infect Immun. 2000 May;68(5):2748-55 - PubMed
  50. J Neurochem. 2011 Dec;119(6):1173-82 - PubMed
  51. Int Immunol. 2000 May;12(5):677-89 - PubMed
  52. Antimicrob Agents Chemother. 2003 Sep;47(9):2804-9 - PubMed
  53. J Leukoc Biol. 2003 Sep;74(3):448-55 - PubMed
  54. Cancer Res. 2009 Mar 15;69(6):2375-83 - PubMed
  55. J Immunol. 2006 Jun 1;176(11):6512-22 - PubMed
  56. J Immunol. 2004 Jan 15;172(2):1146-56 - PubMed
  57. Mol Cell Biol. 2007 Feb;27(3):983-92 - PubMed
  58. J Immunol. 2007 Sep 15;179(6):3958-65 - PubMed
  59. Antimicrob Agents Chemother. 2008 Jul;52(7):2599-607 - PubMed
  60. J Infect Dis. 2007 Mar 1;195(5):684-93 - PubMed
  61. PLoS One. 2010 Apr 23;5(4):e10321 - PubMed
  62. Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3414-9 - PubMed
  63. Crit Rev Immunol. 2008;28(3):185-200 - PubMed
  64. J Biol Chem. 1994 Jun 10;269(23):16075-81 - PubMed
  65. Blood. 2000 Nov 1;96(9):3086-93 - PubMed
  66. Nat Rev Microbiol. 2005 Mar;3(3):238-50 - PubMed
  67. Blood. 2001 Jun 15;97(12):3951-9 - PubMed
  68. Biochem Biophys Res Commun. 2010 Jun 11;396(4):1060-4 - PubMed
  69. J Clin Invest. 1989 Dec;84(6):2017-20 - PubMed
  70. Virulence. 2010 Sep-Oct;1(5):440-64 - PubMed
  71. J Am Acad Dermatol. 2005 Mar;52(3 Pt 1):381-90; quiz 391-2 - PubMed
  72. Infect Immun. 2002 Jun;70(6):3053-60 - PubMed
  73. J Reprod Immunol. 2008 Oct;79(1):37-43 - PubMed
  74. Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1885-90 - PubMed
  75. Infect Immun. 2009 Apr;77(4):1664-78 - PubMed
  76. Nat Immunol. 2005 Jan;6(1):57-64 - PubMed
  77. PLoS One. 2009;4(3):e4769 - PubMed
  78. Nat Immunol. 2001 Dec;2(12):1133-7 - PubMed
  79. Oncogene. 2008 Nov 20;27(54):6856-65 - PubMed
  80. N Engl J Med. 2002 Oct 10;347(15):1151-60 - PubMed
  81. Cell. 1997 Feb 21;88(4):553-60 - PubMed
  82. Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8880-5 - PubMed
  83. Nature. 2002 Jan 24;415(6870):389-95 - PubMed
  84. J Immunol. 2005 May 1;174(9):5490-8 - PubMed
  85. J Biol Chem. 2007 Oct 19;282(42):30794-803 - PubMed
  86. Science. 2006 Mar 24;311(5768):1770-3 - PubMed
  87. EMBO J. 2006 Nov 29;25(23):5569-78 - PubMed
  88. Nature. 2001 Nov 22;414(6862):454-7 - PubMed
  89. Biochem Biophys Res Commun. 1999 Feb 24;255(3):703-6 - PubMed
  90. J Neurochem. 2009 May;109 Suppl 1:117-25 - PubMed
  91. Am J Pathol. 2000 Jun;156(6):1937-50 - PubMed
  92. Nat Rev Microbiol. 2004 Sep;2(9):727-38 - PubMed
  93. Immunity. 2005 Sep;23(3):331-42 - PubMed
  94. J Immunol. 2009 Jan 1;182(1):507-14 - PubMed
  95. Infect Immun. 2002 Jun;70(6):3068-72 - PubMed
  96. FASEB J. 2006 Oct;20(12):2068-80 - PubMed
  97. Nat Rev Immunol. 2003 Sep;3(9):710-20 - PubMed
  98. Blood. 2009 Jun 4;113(23):5848-56 - PubMed
  99. Cell Mol Life Sci. 2008 Oct;65(19):3019-27 - PubMed
  100. Cytokine. 2008 Nov;44(2):248-55 - PubMed

Publication Types